News MSD discontinues Phase III BELLWAVE-011 trial of nemtabrutinib MSD’s BELLWAVE clinical programme includes Phase III trials, BELLWAVE-008 and BELLWAVE-010. Salong Debbarma
Analyst Comment Thousands potentially exposed to measles at religious gathering in Kentucky GlobalData Healthcare